The interferons. Mechanisms of action and clinical applications

S. Baron, S. K. Tyring, W. R. Fleischmann Jr, D. H. Coppenhaver, D. W. Niesel, G. R. Klimpel, G. J. Stanton and T. K. Hughes
Department of Microbiology, University of Texas Medical Branch, Galveston 77550.

The interferons (IFN) are one of the body's natural defensive responses to such foreign components as microbes, tumors, and antigens. The IFN response begins with the production of the IFN proteins (alpha, beta, and gamma), which then induce the antiviral, antimicrobial, antitumor, and immunomodulatory actions of IFN. Recent advances have led to Food and Drug Administration approval of five clinical indications for IFN. Interferon alfa is approved for hairy-cell leukemia, condyloma acuminatum, Kaposi's sarcoma in the acquired immunodeficiency syndrome, and non-A, non-B (type C) viral hepatitis. Interferon gamma has properties distinctive from those of IFNs alpha and beta and is approved as an immunomodulatory treatment for chronic granulomatous disease. Promising clinical results with IFNs have also been reported for basal cell carcinoma, chronic myelogenous leukemia, cutaneous squamous cell carcinoma, early human immunodeficiency virus infection, hepatitis B, and laryngeal papillomatosis. Future clinical uses of IFNs may emphasize combination therapy with other cytokines, chemotherapy, radiation, surgery, hyperthermia, or hormones.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of paroxetine in interferon-{alpha}-induced immune and behavioural changes in male Wistar rats
Myint et al.
J Psychopharmacol 2007;21:843-850.
ABSTRACT  

Quantification of Poly(I:C)-Mediated Protection against Genital Herpes Simplex Virus Type 2 Infection.
Herbst-Kralovetz and Pyles
J. Virol. 2006;80:9988-9997.
ABSTRACT | FULL TEXT  

Variation in Interferon Sensitivity and Induction among Strains of Eastern Equine Encephalitis Virus
Aguilar et al.
J. Virol. 2005;79:11300-11310.
ABSTRACT | FULL TEXT  

Neuromodulation by a Cytokine: Interferon-{beta} Differentially Augments Neocortical Neuronal Activity and Excitability
Hadjilambreva et al.
J. Neurophysiol. 2005;93:843-852.
ABSTRACT | FULL TEXT  

Interferon-{alpha}-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects
Carella et al.
J. Clin. Endocrinol. Metab. 2004;89:3656-3661.
FULL TEXT  

Effect of Interferon-{gamma} on the Pharmacokinetics of Digoxin, a P-glycoprotein Substrate, Intravenously Injected into the Mouse
Kawaguchi et al.
J. Pharmacol. Exp. Ther. 2004;308:91-96.
ABSTRACT | FULL TEXT  

Gelatinase B/matrix metalloproteinase-9 cleaves interferon-{beta} and is a target for immunotherapy
Nelissen et al.
Brain 2003;126:1371-1381.
ABSTRACT | FULL TEXT  

Expression of a Novel Murine Type I IFN in the Pancreatic Islets Induces Diabetes in Mice
Vassileva et al.
J. Immunol. 2003;170:5748-5755.
ABSTRACT | FULL TEXT  

Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication
Wang et al.
J. Virol. 2003;77:3898-3912.
ABSTRACT | FULL TEXT  

Diagnostic Significance of Interferon-{gamma} in Tuberculous Pleural Effusions
Aoe et al.
Chest 2003;123:740-744.
ABSTRACT | FULL TEXT  

Alteration of Intrinsic Biological Rhythms during Interferon Treatment and Its Possible Mechanism
Koyanagi and Ohdo
Mol. Pharmacol. 2002;62:1393-1399.
ABSTRACT | FULL TEXT  

Interferons Inhibit Tumor Necrosis Factor-alpha -mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-kappa B
Sanceau et al.
J. Biol. Chem. 2002;277:35766-35775.
ABSTRACT | FULL TEXT  

Experimental and calculated parameters on particle phagocytosis by alveolar macrophages
Camner et al.
J. Appl. Physiol. 2002;92:2608-2616.
ABSTRACT | FULL TEXT  

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Burroughs et al.
Gut 2002;50:425-427.
ABSTRACT | FULL TEXT  

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase
Lee et al.
Blood 2001;98:3205-3211.
ABSTRACT | FULL TEXT  

Interferon Regulatory Factor 4 Contributes to Transformation of v-Rel-Expressing Fibroblasts
Bose
Mol. Cell. Biol. 2001;21:6369-6386.
ABSTRACT | FULL TEXT  

Treatment with Low-Dose Interferon-{alpha} Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder
Slaton et al.
Clin. Cancer Res. 2001;7:2840-2853.
ABSTRACT | FULL TEXT  

Interferon-gamma Stimulates Fractalkine Expression in Human Bronchial Epithelial Cells and Regulates Mononuclear Cell Adherence
Fujimoto et al.
Am. J. Respir. Cell Mol. Bio. 2001;25:233-238.
ABSTRACT | FULL TEXT  

Meningioma Treated with Interferon-{alpha}, Evaluated with [11C]-L-Methionine Positron Emission Tomography
Muhr et al.
Clin. Cancer Res. 2001;7:2269-2276.
ABSTRACT | FULL TEXT  

The Immune Response to Ocular Herpes Simplex Virus Type 1 Infection
Carr et al.
Exp. Biol. Med. 2001;226:353-366.
ABSTRACT | FULL TEXT  

Randomized Placebo-Controlled Evaluation of Intramuscular Interferon Beta Treatment of Recurrent Human Papillomavirus
GONZALEZ-SANCHEZ et al.
Obstet Gynecol 2001;97:621-624.
ABSTRACT | FULL TEXT  

Chronopharmacology of Antitumor Effect Induced by Interferon-beta in Tumor-Bearing Mice
Takane et al.
J. Pharmacol. Exp. Ther. 2000;294:746-752.
ABSTRACT | FULL TEXT  

Psychiatric Side Effects of Interferon Therapy: Prevalence, Proposed Mechanisms, and Future Directions
Trask et al.
JCO 2000;18:2316-2326.
ABSTRACT | FULL TEXT  

Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry
Giralt et al.
Blood 2000;95:410-415.
ABSTRACT | FULL TEXT  

p53 Expression and Relation to Human Papillomavirus Infection in Pingueculae, Pterygia, and Limbal Tumors
Dushku et al.
Arch Ophthalmol 1999;117:1593-1599.
ABSTRACT | FULL TEXT  

Interferon-{{alpha}}-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule
Slaton et al.
Clin. Cancer Res. 1999;5:2726-2734.
ABSTRACT | FULL TEXT  

Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy
Pawlotsky et al.
J. Virol. 1999;73:6490-6499.
ABSTRACT | FULL TEXT  

Ectopic Expression of DNA Encoding IFN-{alpha}1 in the Cornea Protects Mice from Herpes Simplex Virus Type 1-Induced Encephalitis
Noisakran et al.
J. Immunol. 1999;162:4184-4190.
ABSTRACT | FULL TEXT  

IFN-{alpha} 2B Enhances Th1 Cytokine Responses in Bladder Cancer Patients Receiving Mycobacterium bovis Bacillus Calmette-Guerin Immunotherapy
Luo et al.
J. Immunol. 1999;162:2399-2405.
ABSTRACT | FULL TEXT  

Astrocyte-Targeted Expression of IFN-{alpha}1 Protects Mice from Acute Ocular Herpes Simplex Virus Type 1 Infection
Carr et al.
J. Immunol. 1998;161:4859-4865.
ABSTRACT | FULL TEXT  

Transgenic Expression of IFN-{alpha} in the Central Nervous System of Mice Protects Against Lethal Neurotropic Viral Infection but Induces Inflammation and Neurodegeneration
Akwa et al.
J. Immunol. 1998;161:5016-5026.
ABSTRACT | FULL TEXT  

p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by alpha -Interferon
Thomas et al.
J. Biol. Chem. 1998;273:23659-23667.
ABSTRACT | FULL TEXT  

Association Between Pretransplant Interferon-alpha and Outcome After Unrelated Donor Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase
Morton et al.
Blood 1998;92:394-401.
ABSTRACT | FULL TEXT  

Antituberculosis Drug-induced Hepatotoxicity . The Role of Hepatitis C Virus and the Human Immunodeficiency Virus
UNGO et al.
Am. J. Respir. Crit. Care Med. 1998;157:1871-1876.
ABSTRACT | FULL TEXT  

Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations
Pawlotsky et al.
J. Virol. 1998;72:2795-2805.
ABSTRACT | FULL TEXT  

Age-Dependent Levels of Select Immunological Mediators in Sera of Healthy Children
Sack et al.
CVI 1998;5:28-32.
ABSTRACT | FULL TEXT  

Therapeutic Applications of Alpha Interferon for Chronic Viral Hepatitis in Pediatric Patients
Kay and Wyllie
CLIN PEDIATR 1995;34:372-379.
 

Treatment of Chronic Hepatitis D with Interferon Alfa-2a
Farci et al.
NEJM 1994;330:88-94.
ABSTRACT | FULL TEXT